Gut-inhabiting enterobacter increases subcutaneous fat mass

June 1, 2018, University of Jyväskylä

A research project performed at the universities of Jyväskylä and Turku studied the effects of a specific gut enterobacterium on body fat mass.

The researchers administered either live enterobacterium or a to intragastrically over a 12-week period. The mice that received the enterobacterium had significantly higher subcutaneous than the mice that received saline.

"In addition, we noted that the size of the adipocytes was greater, which is an indication of hypertrophic obesity. This may be the reason for that their seemed less insulin sensitive. Insulin regulates the metabolism of carbohydrates and fats in the body," says the project's principal investigator, Academy of Finland Researcher Satu Pekkala, from the Faculty of Sport and Health Sciences at the University of Jyväskylä.

Pekkala's research group also found that the enterobacterium caused liver damage in the mice. This was seen in increased concentrations of liver damage markers—aspartate aminotransferase (AST) and alanine aminotransferase (ALT) - in the blood. The researchers were expecting to find liver fat accumulation in the mice but this was not the case. Instead, they found increased fibrosis in the liver. Fibrosis is the formation of excess fibrous connective tissue in an organ. In advanced fibrosis, the hepatic cells are destroyed, leading to the replacement of normal tissue by , then to a decline in the synthetic and secretory processes and finally to cirrhosis of the liver.

The researchers selected Enterobacter cloacae (ATCC 13047) for the study because an earlier report had found its phylogenetically close relative, Enterobacter B29, in a morbidly obese Chinese patient."In the future," Pekkala says, "it would be interesting to study how frequently the abundance of gut enterobacteria is increased in obesity and , and whether and how we could affect their abundance as a means to possibly reverse the health-compromising effects."

Explore further: Gut microbe may improve fatty liver

More information: Anniina Keskitalo et al, Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice, PLOS ONE (2018). DOI: 10.1371/journal.pone.0198262

Related Stories

Gut microbe may improve fatty liver

April 5, 2017
Oral administration of a commensal gut microbe, Faecalibacterium prausnitzii, improves fatty liver in mice. F. prausnitzii is considered one of the most important bacterial indicators of a healthy gut. It has been shown to ...

Hepatic fat accumulation may have causal role in liver disease

January 11, 2018
(HealthDay)—Hepatic fat accumulation may play a causal role in chronic liver disease, according to a study published online Dec. 27 in the Journal of Internal Medicine.

Peptide improves glucose and insulin sensitivity, lowers weight in mice

February 8, 2018
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School ...

Chilli peppers hold promise of preventing liver damage and progression

April 23, 2015
Results revealed today at the International Liver Congress 2015 show that the daily consumption of capsaicin, the active compound of chilli peppers, was found to have beneficial effects on liver damage.

Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

June 19, 2017
Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by abnormal accumulation of fat in the liver. NAFLD is diagnosed in up to one in three adults and one in 10 children in the United States, and obesity ...

Stellate cells in the liver control regeneration and fibrosis

February 24, 2015
Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem. An estimated ten percent of the population is affected by liver fibrosis or its corresponding later stage, liver ...

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.